(Q39028837)

8 September 2017

title

Preparation and evaluation of carborane-derived inhibitors of prostate specific membrane antigen (PSMA). (English)

1 reference

8 September 2017

Mohamed E El-Zaria

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481236%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Afaf R Genady

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481236%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Christina I Petlura

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481236%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

John F Valliant

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481236%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

language of work or name

English

0 references

publication date

1 April 2014

1 reference

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481236%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481236%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481236%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

4950-4961

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481236%20AND%20SRC:MED&resulttype=core&format=json

The radiobiological principles of boron neutron capture therapy: a critical review

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Apoptosis through Bcl-2/Bax and cleaved caspase up-regulation in melanoma treated by boron neutron capture therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

The Chemistry of Neutron Capture Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Biological evaluation of dodecaborate-containing L-amino acids for boron neutron capture therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Boron neutron capture therapy demonstrated in mice bearing EMT6 tumors following selective delivery of boron by rationally designed liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

New classes of carborane-appended 5-thio-D-glucopyranose derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Mercaptocarborane-capped gold nanoparticles: electron pools and ion traps with switchable hydrophilicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Boron in drug discovery: carboranes as unique pharmacophores in biologically active compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Carbaboranes as pharmacophores: properties, synthesis, and application strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Interaction of fluorescently substituted metallacarboranes with cyclodextrins and phospholipid bilayers: fluorescence and light scattering study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Boron neutron capture in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Tissue disposition of 5-o-carboranyluracil--a novel agent for the boron neutron capture therapy of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Perspectives on treatment of metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Targeting Metastatic Prostate Cancer With Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Prostate-specific membrane antigen-based imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Anti-prostate-specific membrane antigen-based radioimmunotherapy for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Synthesis and SAR of ⁹⁹mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

123I-MIP-1072, a small-molecule inhibitor of prostate-specific membrane antigen, is effective at monitoring tumor response to taxane therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

First-in-man evaluation of 2 high-affinity PSMA-avid small molecules for imaging prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Spacer length effects on in vitro imaging and surface accessibility of fluorescent inhibitors of prostate specific membrane antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Asborin: the carbaborane analogue of aspirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Carbaboranes as pharmacophores: similarities and differences between aspirin and asborin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Ortho-carbaborane derivatives of indomethacin as cyclooxygenase (COX)-2 selective inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Synthesis of 3-Amino-1-carboxy-o-carborane and an Improved, General Method for the Synthesis of All Three C-Amino-C-carboxycarboranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Triazole Appending Agent (TAAG): A New Synthon for Preparing Iodine-Based Molecular Imaging and Radiotherapy Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Applications of Radiolabeled Boron Clusters to the Diagnosis and Treatment of Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Synthesis, biological evaluation, and radioiodination of halogenated closo-carboranylthymidine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Conjugation of phenyl isothiocyanate derivatives of carborane to antitumor antibody and in vivo localization of conjugates in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Bispecific antibody mediated targeting of nido-carboranes to human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Synthesis and characterization of oligomeric nido-carboranyl phosphate diester conjugates to antibody and antibody fragments for potential use in boron neutron capture therapy of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

An admonition when measuring the lipophilicity of radiotracers using counting techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Reagents for astatination of biomolecules: comparison of the in vivo distribution and stability of some radioiodinated/astatinated benzamidyl and nido-carboranyl compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

Carboranyl-porphyrazines and derivatives for boron neutron capture therapy: From synthesis to in vitro tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC3DT53189A

21 January 2018

Identifiers

DOI

10.1039/C3DT53189A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24481236%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

1 reference